Atara Biotherapeutics, Inc.
ATRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604464
In the last 90 days, Atara Biotherapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 36 institutions reported holding it in 13F filings for Q2 2026, worth $51.3M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Atara Biotherapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 145 | 1 | 140 | −4 |
| Shares | 86.0M | 30.5K | 89.7M | +3.75M (+4.4%) |
| Value | $1.34B | $475.0K | $1.61B | +$269.1M (+20.1%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lion Point Capital, LP | 350,465 | $6.27M | 1.66% |
| Integral Health Asset Management, LLC | 200,000 | $3.58M | 1.03% |
| Natixis | 127,700 | $2.29M | 0.01% |
| Public Sector Pension Investment Board | 86,000 | $1.54M | 0.01% |
| Ensign Peak Advisors, Inc | 68,720 | $1.23M | 0.00% |
| Franklin Resources Inc | 30,500 | $546.0K | 0.00% |
| Trexquant Investment LP | 27,248 | $488.0K | 0.04% |
| Ergoteles LLC | 20,987 | $376.0K | 0.01% |
| Connor, Clark & Lunn Investment Management Ltd. | 15,964 | $286.0K | 0.00% |
| Group One Trading, L.P. | 13,838 | $248.0K | 0.01% |
| Americana Partners, LLC | 13,025 | $233.0K | 0.06% |
| Teacher Retirement System of Texas | 11,451 | $205.0K | 0.00% |
| LPL Financial LLC | 10,120 | $181.0K | 0.00% |
| Gerber Kawasaki Wealth & Investment Management | 210 | $3.00K | 0.00% |
| Berman Capital Advisors, LLC | 77 | $1.00K | 0.00% |
Sold out (19)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Healthcare of Ontario Pension Plan Trust Fund | 165,000 | $2.57M |
| Jacobs Levy Equity Management, Inc | 116,722 | $1.81M |
| Alpha Paradigm Partners, LLC | 97,980 | $1.52M |
| Bank of Montreal | 77,177 | $1.28M |
| Prelude Capital Management, LLC | 79,784 | $1.24M |
| Copernicus Capital Management, LLC | 50,000 | $778.0K |
| AQR Capital Management LLC | 26,559 | $413.0K |
| Blueshift Asset Management, LLC | 22,451 | $349.0K |
| Engineers Gate Manager LP | 21,330 | $332.0K |
| Russell Investments Group, Ltd. | 20,898 | $324.0K |
| Qube Research & Technologies Ltd | 19,606 | $305.0K |
| HRT Financial LP | 17,335 | $269.0K |
| Private Capital Advisors, Inc. | 15,000 | $233.0K |
| Virtu Financial LLC | 12,680 | $197.0K |
| ExodusPoint Capital Management, LP | 12,438 | $193.0K |
| Amundi | 11,913 | $185.0K |
| AXA S.A. | 10,635 | $165.0K |
| Quantbot Technologies LP | 1,745 | $27.0K |
| Meeder Asset Management Inc | 309 | $5.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Atara Biotherapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 30,500 | $475.0K |